1. Home
  2. NTNX vs RDY Comparison

NTNX vs RDY Comparison

Compare NTNX & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nutanix Inc.

NTNX

Nutanix Inc.

HOLD

Current Price

$55.04

Market Cap

13.9B

Sector

Technology

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$11.79

Market Cap

11.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTNX
RDY
Founded
2009
1984
Country
United States
India
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9B
11.8B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
NTNX
RDY
Price
$55.04
$11.79
Analyst Decision
Buy
Strong Buy
Analyst Count
19
1
Target Price
$62.29
$16.90
AVG Volume (30 Days)
3.3M
3.1M
Earning Date
05-27-2026
05-12-2026
Dividend Yield
N/A
0.52%
EPS Growth
227.45
N/A
EPS
0.82
N/A
Revenue
$2,537,927,000.00
N/A
Revenue This Year
$13.44
$7.72
Revenue Next Year
$13.03
$3.50
P/E Ratio
$64.18
$18.67
Revenue Growth
18.11
N/A
52 Week Low
$34.01
$11.36
52 Week High
$82.42
$15.67

Technical Indicators

Market Signals
Indicator
NTNX
RDY
Relative Strength Index (RSI) 58.45 32.74
Support Level $44.85 N/A
Resistance Level $58.65 $13.96
Average True Range (ATR) 2.30 0.39
MACD -0.25 -0.21
Stochastic Oscillator 39.83 15.77

Price Performance

Historical Comparison
NTNX
RDY

About NTNX Nutanix Inc.

Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company operates a single operating and reportable segment based on a subscription business model. It conducts business in the United States, Europe, the Middle East and Africa, Asia Pacific, and other Americas, with key revenue generated from the United States.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: